Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS reforms turn to ‘family health services’

May 24, 2005

Five years into the programme of reforms started with the NHS Plan, attention has turned to the services provided by …

News

Pfizer becomes competitive in oncology

May 24, 2005
Research and Development, Sales and Marketing

Pfizer looks set to become a serious contender in oncology with its promising phase III kidney cancer drug Sutent.Until now …

News

Pharma and biotech target growing cancer sector

May 24, 2005
Sales and Marketing

Pharma and biotech companies presented a welter of data at this year's ASCO cancer conference, highlighting the growing importance of …

News

Industry and agencies pour cold water on global procurement

May 19, 2005
Medical Communications

Global procurement processes don't deliver best value and are frequently flawed, according to speakers at the Pharmaceutical Society's annual Question …

News

Smoking vaccine company seeks big pharma partner

May 17, 2005
Research and Development, Sales and Marketing

News

Shire plans four key drug filings

May 17, 2005
Sales and Marketing

Shire Pharmaceuticals hopes to strengthen its ADHD portfolio and establish itself in the global gastrointestinal market with a number of …

News

Strutt appointed to Crestor global PR role

May 16, 2005
Medical Communications

AstraZeneca has made a key appointment to its global PR for its statin brand Crestor.Ben Strutt spent six years as …

News

Hewitt to press ahead with NHS reform

May 13, 2005

News

Roche raise sales expectations

May 12, 2005
Sales and Marketing

Roche has raised its full-year sales forecast after strong first quarter results saw the Swiss company outperform a number of …

News

Monoclonal antibody sales set to rocket

May 12, 2005
Sales and Marketing

The monoclonal antibody market will treble in size to $30 billion by 2010, according to a report by analysts Datamonitor.Datamonitor …

News

Novartis files novel iron overload treatment

May 12, 2005
Sales and Marketing

A new treatment for the rare and difficult to treat condition of chronic iron overload has been filed by Novartis …

News

FDA approves Requip for restless legs syndrome

May 12, 2005
Sales and Marketing

GlaxoSmithKline's Requip has become the first medicine to receive US approval for the treatment of restless legs syndrome (RLS), after …

News

Increasing salesforce effectiveness

May 11, 2005
Sales and Marketing

Pfizer will cut costs worth $4 billion over the next three years in an attempt to return to double-digit earnings …

Feature

10 Brand Blunders…And How to Avoid Them

May 10, 2005
Sales and Marketing

1) Stay loyal to the core brand message and never undermine itIt may have seemed a good idea at the …

Feature

Stepping out: the contract salesforce

May 10, 2005
Sales and Marketing

Sales forces in the pharmaceutical industry account for around 75% of marketing budgets, and are coming under increasing pressure to …

Feature

Gilmartin to leave troubled Merck

May 6, 2005
Sales and Marketing

Raymond Gilmartin has stood down as chief executive and chairman of Merck, drawing a line under long-running uncertainty regarding the …

News

Charity aiming to ‘hit diabetes for six’

May 6, 2005

News

Health helps Labour win third term

May 6, 2005

News

GSK makes strategic biotech acquisition

May 6, 2005
Research and Development, Sales and Marketing GSK, biotech

 GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …

News

Crestor sales top $1 billion for AstraZeneca

May 6, 2005
Sales and Marketing

AstraZeneca's Crestor has achieved blockbuster status, despite continuing concerns over its safety, registering sales of over $1 billion for the …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026